HD
54
5
CB
50
4
UAL
85
2
CMCSA
53
-11
XRX
37
2
DG
10
2
NEM
42
10
EQT
54
3
CRM
67
2
RRC
58
5
PCG
91
3
GE
71
7
FLR
52
-17
HSY
34
3
CL
50
3
SCHW
56
3
ISRG
77
2
STZ
50
2
USB
53
3
PGR
64
2
HD
54
5
CB
50
4
UAL
85
2
CMCSA
53
-11
XRX
37
2
DG
10
2
NEM
42
10
EQT
54
3
CRM
67
2
RRC
58
5
PCG
91
3
GE
71
7
FLR
52
-17
HSY
34
3
CL
50
3
SCHW
56
3
ISRG
77
2
STZ
50
2
USB
53
3
PGR
64
2
Financhill
Back

Repligen Vs. Ascendis Pharma AS Industry Stock Comparison

Buy
53

RGEN
Repligen

Last Price:
140.60
Seasonality Move:
9.8%
Sell
25

ASND
Ascendis Pharma AS

Last Price:
124.12
Seasonality Move:
11.25%
Buy
53
Repligen (RGEN) is a Buy

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $140.64. The Score for RGEN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • RGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $124.33. The Score for ASND is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $140.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $124.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 49.73 Sell
Chaikin Money Flow: -257591 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (135.17 - 144.05) Buy
Bollinger Bands (100): (128.56 - 153.26) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.39 Sell
Relative Strength Index (14 RSI): 40.9 Sell
Chaikin Money Flow: -343585 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.76 - 133.22) Sell
Bollinger Bands (100): (125.03 - 141.83) Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 140.67 Sell
20-day SMA: 140.54 Buy
50-day SMA: 141.74 Sell
200-day SMA: 158.82 Sell
8-day EMA: 141.43 Sell
20-day EMA: 140.66 Sell
50-day EMA: 141.91 Sell
200-day EMA: 151.82 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.61 Sell
20-day SMA: 127.56 Sell
50-day SMA: 132.48 Sell
200-day SMA: 137.31 Sell
8-day EMA: 126.45 Sell
20-day EMA: 128.47 Sell
50-day EMA: 131.53 Sell
200-day EMA: 130.72 Sell

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.38 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $4.28 per share.

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):